FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to forecasting in cardiovascular pathology. Patient at the stage of primary medical and social care after discharge from the hospital, the doctor calculates the risk of adverse clinical outcome (RACO) using the original formula. And if the value of RACO is negative, the probability of an adverse clinical outcome is low. If the value of RACO is positive or equal to zero, the probability of developing an adverse clinical outcome is high.
EFFECT: method allows accurate and timely prediction of the risk of adverse clinical outcome in patients with atrial fibrillation after a cardioembolic stroke, and performing the necessary prophylaxis.
1 cl, 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ESTIMATING THE REHABILITATION POTENTIAL OF A PATIENT WITH RECENTLY SUFFERED ISCHEMIC STROKE | 2021 |
|
RU2777805C1 |
| METHOD OF PREDICTING RISK OF DEVELOPING ACUTE DECOMPENSATION OF HEART FAILURE IN PATIENTS WITH LOW LEFT VENTRICULAR EJECTION FRACTION AND IMPLANTED CARDIOVERTER-DEFIBRILLATOR | 2023 |
|
RU2809775C1 |
| METHOD FOR ASSESSING THE RISK OF UNFAVOURABLE OUTCOME OF ACUTE MYOCARDIAL INFARCTION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS | 2021 |
|
RU2790520C1 |
| METHOD OF PREDICTION OF POSTOPERATIVE CARDIAC ISCHEMIC COMPLICATIONS IN A PATIENT WITH LUNG CANCER | 2022 |
|
RU2798781C1 |
| METHOD FOR DETERMINING ETIOLOGY OF CHRONIC HEART FAILURE | 2020 |
|
RU2748529C1 |
| METHOD FOR PREDICTING AN UNFAVORABLE OUTCOME IN PATIENTS WITH ISCHEMIC STROKE | 2021 |
|
RU2769488C1 |
| METHOD FOR PREDICTING THE OUTCOME OF AN ACUTE PERIOD OF ISCHEMIC STROKE IN PATIENTS NOT SUFFERING TYPE 2 DIABETES MELLITUS | 2019 |
|
RU2731177C1 |
| METHOD FOR DETERMINING THE PROBABILITY OF CEREBRAL AND NON-CEREBRAL THROMBOEMBOLIA OF THE PULMONARY ARTERIES | 2018 |
|
RU2710213C1 |
| METHOD FOR PREDICTION OF CHANGING FUNCTIONAL CLASS OF DISEASE IN PATIENTS WITH CHRONIC CARDIAC FAILURE | 2008 |
|
RU2386973C1 |
| METHOD FOR PREDICTION OF REMOTE UNFAVORABLE OUTCOMES IN PATIENTS WITH HEART FAILURE AND IMPLANTED CARDIOVERTER-DEFIBRILLATOR | 2023 |
|
RU2819279C1 |
